journal article·2023-07Open access

Systematic Analysis of Tissue‐Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer

Jeevan Larson, Mehmet Ozgun Ozen, Manish Kohli, Demir Akin, Utkan Demirci

Advanced Biology· Volume 7· Issue 7

Abstract

Abstract Extracellular vesicles (EVs) are emerging as biomarker candidates for early detection of prostate cancer. Studies compare EV‐microRNA (miRNA) expression in individuals with prostate cancer (PCa) with cancer‐free samples for diagnostic purposes. The aim of this study is to review miRNA signatures to investigate the overlap between miRNAs enriched in PCa tissue and miRNAs enriched in EVs isolated from subjects with PCa biofluids (i.e., urine, serum, and plasma). Signatures dysregulated in EVs from PCa biofluids and tissue are potentially associated with the primary tumor site and might be more indicative of PCa at an early stage. A systematic review of EV‐derived miRNAs and a reanalysis of PCa tissue miRNA sequencing data for comparison is presented. Articles in the literature are screened for validated miRNA dysregulation in PCa and compared with TCGA primary PCa tumor data using DESeq2. This resulted in 190 dysregulated miRNAs being identified. Thirty‐one eligible studies are identified, indicating 39 dysregulated EV‐derived miRNAs. The top ten markers identified as significantly dysregulated in the PCa tissue dataset TCGA (e.g., miR‐30b‐3p, miR‐210‐3p, miR‐126‐3p, and miR‐196a‐5p) have a significant expression change in EVs with the same directionality in one or several statistically significant results. This analysis highlights several less frequently studied miRNAs in PCa literature.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Circular RNAs in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology Canary Center for Cancer Early Detection Bioacoustic MEMS in Medicine (BAMM) Labs Stanford University 94305 Stanford USA

Huntsman Cancer Institute University of Utah 84112 Salt Lake City USA

Department of Electrical Engineering (by courtesy) Stanford University 94305 Stanford USA

References (75)

Show source-provided references
1. Leslie et al. Prostate Cancer StatPearls – NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK470550/#:~:text=According%20to%20the%20American%20Ctherancer the%20United%20States%20in%202022 accessed: March 11 2023.
2. 10.3322/caac.2166010.3322/caac.21660 ↗
3. 10.1002/0471143030.cb0322s3010.1002/0471143030.cb0322s30 ↗
4. 10.1186/s12943-016-0523-510.1186/s12943-016-0523-5 ↗
5. 10.3390/ijms2118648610.3390/ijms21186486 ↗
6. 10.7150/thno.3948610.7150/thno.39486 ↗
7. 10.1007/s11864-018-0527-z10.1007/s11864-018-0527-z ↗
8. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
9. 10.1371/journal.pone.015756610.1371/journal.pone.0157566 ↗
10. 10.5152/tud.2019.1916310.5152/tud.2019.19163 ↗
11. 10.3390/ijms2121833010.3390/ijms21218330 ↗
12. 10.1186/s12885-017-3737-z10.1186/s12885-017-3737-z ↗
13. 10.1002/pros.2329510.1002/pros.23295 ↗
14. Amunategui M. · Github.Io · 2015 · 1
15. S.Kovalchik RISmed (2.3.0)2021 https://cran.r‐project.org/web/packages/RISmed/RISmed.pdf.
16. The Cancer Genome Atlas Research Network The Molecular Taxonomy of Primary Prostate Cancer | NCI Genomic Data Commons NCI Genomic Data Commons2015 https://gdc.cancer.gov/about‐data/publications/prad_2015.
17. 10.3390/cancers1320523610.3390/cancers13205236 ↗
18. 10.1038/bjc.2011.59510.1038/bjc.2011.595 ↗
19. Guo Z. · Comput. Math. Methods Med. · 2022 · 2022 · 1
20. 10.33393/jcb.2022.231710.33393/jcb.2022.2317 ↗
21. 10.1016/j.bios.2021.11350410.1016/j.bios.2021.113504 ↗
22. 10.1371/journal.pone.026201710.1371/journal.pone.0262017 ↗
23. 10.1016/j.bios.2022.11411610.1016/j.bios.2022.114116 ↗
24. 10.18632/oncotarget.812410.18632/oncotarget.8124 ↗
25. Ku A. · Front. Oncol. · 2021 · 11
26. 10.3390/ijms2313713410.3390/ijms23137134 ↗
27. Li L. · Zhonghua Jianyan Yixue Zazhi · 2017 · 40 · 273
28. 10.4149/neo_2020_191130N123410.4149/neo_2020_191130N1234 ↗
29. 10.2147/CMAR.S27214010.2147/CMAR.S272140 ↗
30. Li Z. · OncoTargets Ther. · 2015 · 139
31. 10.21037/tau-20-42110.21037/tau-20-421 ↗
32. 10.29252/jcbr.3.4.710.29252/jcbr.3.4.7 ↗
33. 10.18632/oncotarget.2453210.18632/oncotarget.24532 ↗
34. 10.3390/cancers1403053210.3390/cancers14030532 ↗
35. 10.1186/s12943-017-0726-410.1186/s12943-017-0726-4 ↗
36. 10.1002/pros.2310110.1002/pros.23101 ↗
37. 10.7150/thno.4918610.7150/thno.49186 ↗
38. 10.7150/jca.7170610.7150/jca.71706 ↗
39. 10.3390/cancers1201004310.3390/cancers12010043 ↗
40. 10.1002/pros.2337610.1002/pros.23376 ↗
41. 10.3390/cells1009237210.3390/cells10092372 ↗
42. 10.7717/peerj.1144110.7717/peerj.11441 ↗
43. G. H. G.Database GeneCards – Human Genes | Gene Database | Gene Search https://www.genecards.org/ n.d.
44. 10.1002/cpbi.510.1002/cpbi.5 ↗
45. Safran M. · Practical Guide to Life Science Databases · 2022 · 27
46. 10.1016/j.jmb.2021.16691310.1016/j.jmb.2021.166913 ↗
47. G. H. G.Database GeneCaRNA – The Human ncRNA Database https://www.genecards.org/genecarna n.d.
48. 10.1186/s12943-016-0556-910.1186/s12943-016-0556-9 ↗
49. 10.1186/s13148-015-0076-210.1186/s13148-015-0076-2 ↗
50. 10.1038/s12276-022-00837-610.1038/s12276-022-00837-6 ↗
51. 10.1038/s41419-021-03803-810.1038/s41419-021-03803-8 ↗
52. 10.3390/ijms2207352810.3390/ijms22073528 ↗
53. 10.18632/oncotarget.2201410.18632/oncotarget.22014 ↗
54. 10.1038/s41419-018-1287-110.1038/s41419-018-1287-1 ↗
55. 10.3390/cancers1410239010.3390/cancers14102390 ↗
56. Ardila H. J. · Mol. Clin. Oncol. · 2019 · 11 · 201
57. 10.3390/cancers1319502010.3390/cancers13195020 ↗
58. 10.1016/j.biopha.2020.10986310.1016/j.biopha.2020.109863 ↗
59. De Souza M. F. · PLoS One · 2017 · 1210.1371/journal.pone.0184094 ↗
60. 10.1002/ijc.3081510.1002/ijc.30815 ↗
61. 10.1111/iju.1270010.1111/iju.12700 ↗
62. 10.21037/atm.2019.02.4010.21037/atm.2019.02.40 ↗
63. 10.1016/j.canlet.2018.04.04410.1016/j.canlet.2018.04.044 ↗
64. 10.18632/oncotarget.1224110.18632/oncotarget.12241 ↗
65. 10.1186/s40659-020-00277-410.1186/s40659-020-00277-4 ↗
66. 10.1038/s41416-020-0836-410.1038/s41416-020-0836-4 ↗
67. Gao D. · Front. Genet. · 2019 · 10
68. 10.1111/jcmm.1527410.1111/jcmm.15274 ↗
69. 10.1186/s12943-017-0688-610.1186/s12943-017-0688-6 ↗
70. 10.1038/bjc.2017.21210.1038/bjc.2017.212 ↗
71. 10.1007/s12253-018-0412-x10.1007/s12253-018-0412-x ↗
72. 10.1002/pros.2403610.1002/pros.24036 ↗
73. 10.1042/BSR2020355910.1042/BSR20203559 ↗
74. 10.1038/s41416-021-01677-310.1038/s41416-021-01677-3 ↗
75. H.Health How to make your prostate biopsy go better‐before during and after https://www.health.harvard.edu/cancer/how‐to‐make‐your‐prostate‐biopsy‐go‐better‐before‐during‐and‐after accessed: December 15 2019 1.